| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $2.79B | +3.3% |
| Cost of Revenue | $1.90B | -1.3% |
| Gross Profit | $886.3M | +14.7% |
| R&D Expense | $124.9M | -9.5% |
| SG&A Expense | $171.4M | +13.2% |
| Operating Income | $590.0M | +22.1% |
| Interest Expense | $57.4M | +53.6% |
| Pre-tax Income | $584.1M | +19.5% |
| Income Tax | $121.7M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $77.5M | -30.8% |
| Accounts Receivable | $395.4M | -8.5% |
| Inventory | $505.4M | +10.8% |
| Current Assets | $1.03B | -1.0% |
| Total Assets | $3.13B | +35.5% |
| Current Liabilities | $374.5M | +2.8% |
| Long-term Debt | $971.3M | +50.9% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $519.6M | -9.9% |
| Capital Expenditures | $57.3M | +18.7% |
| Investing Cash Flow | -$738.8M | -1429.8% |
| Financing Cash Flow | $185.8M | +138.1% |
| Free Cash Flow | $462.3M | -12.5% |
| +21.6% |
| Net Income | $462.4M | +18.9% |
| EPS (Basic) | $48.22 | +19.2% |
| EPS (Diluted) | $48.22 | +19.2% |
| Total Liabilities |
| $1.67B |
| +35.4% |
| Stockholders' Equity | $1.46B | +35.7% |